Greater Noida Facility is now operational!

Connect with us to find out what our State-of-the-Art facility offers.

Delivering the Added Dimension in Drug Discovery

Time is a defining factor in drug discovery today. Our people, systems and processes are honed for delivering the highest quality results to enable our innovator customers to accelerate drug discovery for final IND submission.

Chemistry Innovation Research Centre

A state of the art digitally enabled chemistry research facility with more than 200,000 sqft lab space. Designed for speed and efficiency with Covid-19 measures built in for maximum safety.

Deep & Defining Scientific Know-how

Employing dedicated scientists with over 14 years experience in oncology, metabolic disorders, CNS, pain, inflammation and fibrosis as well as multiple niche therapeutic areas.

Delivering over 80 Integrated Discovery Projects

Our track record of achieving results is our platform for the future. Customers can choose individual functional services or a fully integrated solution.

Developing your Drug Candidate

We rapidly scale-up your candidate for GLP TOX and GMP Phase 1 or 2 fully integrated with our PR&D and Analytical Teams. This saves valuable time to achieve your milestones.

Jubilant Biosys
Contract Research Organisation in India

Jubilant Biosys Ltd is a part of the Jubilant Pharmova family of companies with R&D centers in India and business offices in Asia and North America. With our global reach, Jubilant Biosys provides comprehensive drug discovery services and contract research services - from target discovery to candidate selection and with flexible business models (FFS, FTE and risk shared) - in partnership with leading worldwide healthcare.

Latest News

Jubilant snags $146.6M US contract to Double injectables production

Press Releases

Jubilant Biosys Limited Announces New Chemistry Innovation Research Center to Support Expanded Discovery Chemistry and in-vitro ADME Services for Clients like Turning Point Therapeutics.